25 XP   0   0   10

Forte Biosciences Inc
Buy, Hold or Sell?

Let's analyse Forte Biosciences Inc together

PenkeI guess you are interested in Forte Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Forte Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Forte Biosciences Inc

I send you an email if I find something interesting about Forte Biosciences Inc.

Quick analysis of Forte Biosciences Inc (30 sec.)










What can you expect buying and holding a share of Forte Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€0.91
Expected worth in 1 year
€0.82
How sure are you?
26.7%

+ What do you gain per year?

Total Gains per Share
€-0.09
Return On Investment
-13.6%

For what price can you sell your share?

Current Price per Share
€0.67
Expected price per share
€0.56 - €0.775
How sure are you?
50%

1. Valuation of Forte Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)

€0.67

Intrinsic Value Per Share

€-9.70 - €-11.49

Total Value Per Share

€-8.79 - €-10.58

2. Growth of Forte Biosciences Inc (5 min.)




Is Forte Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$35.3m$39.9m-$6.5m-19.7%

How much money is Forte Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$7.8m-$3.4m-$4.3m-55.9%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Forte Biosciences Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#522 / 1016

Most Revenue
#910 / 1016

Most Profit
#509 / 1016

Most Efficient
#357 / 1016

What can you expect buying and holding a share of Forte Biosciences Inc? (5 min.)

Welcome investor! Forte Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Forte Biosciences Inc.

What can you expect buying and holding a share of Forte Biosciences Inc?

First you should know what it really means to hold a share of Forte Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Forte Biosciences Inc is €0.665. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Forte Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Forte Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.91. Based on the TTM, the Book Value Change Per Share is €-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Forte Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.16-24.3%-0.22-32.5%-0.10-14.3%-0.20-30.7%-0.20-30.7%
Usd Book Value Change Per Share-0.14-21.0%-0.02-3.6%-0.02-2.8%0.069.7%0.069.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.14-21.0%-0.02-3.6%-0.02-2.8%0.069.7%0.069.7%
Usd Price Per Share0.71-0.81-1.21-10.52-10.52-
Price to Earnings Ratio-1.11--0.99--3.45--17.81--17.81-
Price-to-Total Gains Ratio-5.10--3.49--15.03--58.78--58.78-
Price to Book Ratio0.74-0.94-1.11-11.28-11.28-
Price-to-Total Gains Ratio-5.10--3.49--15.03--58.78--58.78-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.707959
Number of shares1412
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.06
Usd Total Gains Per Share-0.020.06
Gains per Quarter (1412 shares)-33.9991.34
Gains per Year (1412 shares)-135.94365.34
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-136-1460365355
20-272-2820731720
30-408-418010961085
40-544-554014611450
50-680-690018271815
60-816-826021922180
70-952-962025572545
80-1088-1098029232910
90-1223-1234032883275
100-1359-1370036533640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.015.00.00.0%0.015.00.00.0%0.015.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%4.011.00.026.7%4.011.00.026.7%4.011.00.026.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.015.00.0%0.00.015.00.0%0.00.015.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%4.011.00.026.7%4.011.00.026.7%4.011.00.026.7%

Fundamentals of Forte Biosciences Inc

About Forte Biosciences Inc

Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

Fundamental data was last updated by Penke on 2024-04-18 04:45:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Forte Biosciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Forte Biosciences Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Forte Biosciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Forte Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--199.6%+199.6%
TTM--213.0%+213.0%
YOY--279.3%+279.3%
5Y--438.4%+438.4%
10Y--605.5%+605.5%
1.1.2. Return on Assets

Shows how efficient Forte Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Forte Biosciences Inc to the Biotechnology industry mean.
  • -15.1% Return on Assets means that Forte Biosciences Inc generated €-0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Forte Biosciences Inc:

  • The MRQ is -15.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -20.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.1%TTM-20.7%+5.6%
TTM-20.7%YOY-8.3%-12.4%
TTM-20.7%5Y-20.8%+0.1%
5Y-20.8%10Y-20.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.1%-13.5%-1.6%
TTM-20.7%-12.9%-7.8%
YOY-8.3%-11.8%+3.5%
5Y-20.8%-14.1%-6.7%
10Y-20.8%-16.0%-4.8%
1.1.3. Return on Equity

Shows how efficient Forte Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Forte Biosciences Inc to the Biotechnology industry mean.
  • -16.6% Return on Equity means Forte Biosciences Inc generated €-0.17 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Forte Biosciences Inc:

  • The MRQ is -16.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -24.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.6%TTM-24.4%+7.7%
TTM-24.4%YOY-8.7%-15.7%
TTM-24.4%5Y-23.4%-1.0%
5Y-23.4%10Y-23.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.6%-16.9%+0.3%
TTM-24.4%-16.1%-8.3%
YOY-8.7%-15.1%+6.4%
5Y-23.4%-19.9%-3.5%
10Y-23.4%-20.9%-2.5%

1.2. Operating Efficiency of Forte Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Forte Biosciences Inc is operating .

  • Measures how much profit Forte Biosciences Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Forte Biosciences Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Forte Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM--225.8%+225.8%
YOY--288.4%+288.4%
5Y--477.4%+477.4%
10Y--625.6%+625.6%
1.2.2. Operating Ratio

Measures how efficient Forte Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Forte Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.090-3.090
TTM-3.264-3.264
YOY-3.783-3.783
5Y-5.679-5.679
10Y-7.894-7.894

1.3. Liquidity of Forte Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Forte Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 10.45 means the company has €10.45 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Forte Biosciences Inc:

  • The MRQ is 10.455. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.822. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.455TTM7.822+2.633
TTM7.822YOY22.589-14.767
TTM7.8225Y16.197-8.375
5Y16.19710Y16.1970.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.4553.914+6.541
TTM7.8224.220+3.602
YOY22.5895.388+17.201
5Y16.1976.045+10.152
10Y16.1976.406+9.791
1.3.2. Quick Ratio

Measures if Forte Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Forte Biosciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 6.86 means the company can pay off €6.86 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Forte Biosciences Inc:

  • The MRQ is 6.864. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.950. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.864TTM2.950+3.914
TTM2.950YOY-+2.950
TTM2.9505Y0.787+2.164
5Y0.78710Y0.7870.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.8643.572+3.292
TTM2.9503.998-1.048
YOY-5.390-5.390
5Y0.7875.969-5.182
10Y0.7876.287-5.500

1.4. Solvency of Forte Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Forte Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Forte Biosciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.09 means that Forte Biosciences Inc assets are financed with 9.4% credit (debt) and the remaining percentage (100% - 9.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Forte Biosciences Inc:

  • The MRQ is 0.094. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.139. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.094TTM0.139-0.045
TTM0.139YOY0.049+0.090
TTM0.1395Y0.082+0.057
5Y0.08210Y0.0820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0940.336-0.242
TTM0.1390.334-0.195
YOY0.0490.269-0.220
5Y0.0820.366-0.284
10Y0.0820.390-0.308
1.4.2. Debt to Equity Ratio

Measures if Forte Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Forte Biosciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 10.4% means that company has €0.10 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Forte Biosciences Inc:

  • The MRQ is 0.104. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.164. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.104TTM0.164-0.060
TTM0.164YOY0.052+0.112
TTM0.1645Y0.093+0.071
5Y0.09310Y0.0930.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1040.382-0.278
TTM0.1640.396-0.232
YOY0.0520.335-0.283
5Y0.0930.434-0.341
10Y0.0930.465-0.372

2. Market Valuation of Forte Biosciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Forte Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Forte Biosciences Inc to the Biotechnology industry mean.
  • A PE ratio of -1.11 means the investor is paying €-1.11 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Forte Biosciences Inc:

  • The EOD is -1.097. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.105. Based on the earnings, the company is expensive. -2
  • The TTM is -0.986. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.097MRQ-1.105+0.008
MRQ-1.105TTM-0.986-0.119
TTM-0.986YOY-3.452+2.466
TTM-0.9865Y-17.810+16.824
5Y-17.81010Y-17.8100.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.097-2.259+1.162
MRQ-1.105-2.569+1.464
TTM-0.986-2.664+1.678
YOY-3.452-4.120+0.668
5Y-17.810-6.258-11.552
10Y-17.810-6.171-11.639
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Forte Biosciences Inc:

  • The EOD is -0.717. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.722. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.152. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.717MRQ-0.722+0.005
MRQ-0.722TTM-1.152+0.429
TTM-1.152YOY-5.887+4.736
TTM-1.1525Y-21.549+20.397
5Y-21.54910Y-21.5490.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.717-2.924+2.207
MRQ-0.722-3.246+2.524
TTM-1.152-3.488+2.336
YOY-5.887-5.620-0.267
5Y-21.549-8.315-13.234
10Y-21.549-8.826-12.723
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Forte Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.74 means the investor is paying €0.74 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Forte Biosciences Inc:

  • The EOD is 0.730. Based on the equity, the company is cheap. +2
  • The MRQ is 0.735. Based on the equity, the company is cheap. +2
  • The TTM is 0.936. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.730MRQ0.735-0.005
MRQ0.735TTM0.936-0.201
TTM0.936YOY1.106-0.170
TTM0.9365Y11.278-10.342
5Y11.27810Y11.2780.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.7301.851-1.121
MRQ0.7352.090-1.355
TTM0.9362.095-1.159
YOY1.1062.844-1.738
5Y11.2783.466+7.812
10Y11.2783.815+7.463
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Forte Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.131-0.023-83%-0.018-87%0.061-316%0.061-316%
Book Value Per Share--0.9110.862+6%1.032-12%1.011-10%1.011-10%
Current Ratio--10.4557.822+34%22.589-54%16.197-35%16.197-35%
Debt To Asset Ratio--0.0940.139-32%0.049+93%0.082+15%0.082+15%
Debt To Equity Ratio--0.1040.164-37%0.052+101%0.093+12%0.093+12%
Dividend Per Share----0%-0%-0%-0%
Eps---0.152-0.203+34%-0.090-41%-0.192+27%-0.192+27%
Free Cash Flow Per Share---0.232-0.186-20%-0.053-77%-0.119-49%-0.119-49%
Free Cash Flow To Equity Per Share---0.234-0.027-89%-0.006-98%0.050-563%0.050-563%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---11.488--------
Intrinsic Value_10Y_min---9.703--------
Intrinsic Value_1Y_max---0.562--------
Intrinsic Value_1Y_min---0.552--------
Intrinsic Value_3Y_max---2.138--------
Intrinsic Value_3Y_min---2.032--------
Intrinsic Value_5Y_max---4.255--------
Intrinsic Value_5Y_min---3.911--------
Market Cap24202608.500-1%24384583.00027731094.055-12%41446512.120-41%359685944.047-93%359685944.047-93%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.730-1%0.7350.936-21%1.106-34%11.278-93%11.278-93%
Pe Ratio-1.097+1%-1.105-0.986-11%-3.452+212%-17.810+1511%-17.810+1511%
Price Per Share0.665-1%0.6700.762-12%1.139-41%9.883-93%9.883-93%
Price To Free Cash Flow Ratio-0.717+1%-0.722-1.152+59%-5.887+715%-21.549+2884%-21.549+2884%
Price To Total Gains Ratio-5.058+1%-5.096-3.493-31%-15.029+195%-58.785+1053%-58.785+1053%
Quick Ratio--6.8642.950+133%-+100%0.787+772%0.787+772%
Return On Assets---0.151-0.207+37%-0.083-45%-0.208+38%-0.208+38%
Return On Equity---0.166-0.244+47%-0.087-48%-0.234+41%-0.234+41%
Total Gains Per Share---0.131-0.023-83%-0.018-87%0.061-316%0.061-316%
Usd Book Value--35313250.63733387791.496+6%39976151.688-12%39162102.296-10%39162102.296-10%
Usd Book Value Change Per Share---0.140-0.024-83%-0.019-87%0.065-316%0.065-316%
Usd Book Value Per Share--0.9700.917+6%1.098-12%1.076-10%1.076-10%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.161-0.216+34%-0.095-41%-0.204+27%-0.204+27%
Usd Free Cash Flow---8985809.317-7198347.248-20%-2046206.579-77%-4614168.752-49%-4614168.752-49%
Usd Free Cash Flow Per Share---0.247-0.198-20%-0.056-77%-0.127-49%-0.127-49%
Usd Free Cash Flow To Equity Per Share---0.249-0.028-89%-0.006-98%0.054-563%0.054-563%
Usd Market Cap25766097.009-1%25959827.06229522522.731-12%44123956.803-41%382921656.032-93%382921656.032-93%
Usd Price Per Share0.708-1%0.7130.811-12%1.212-41%10.521-93%10.521-93%
Usd Profit---5871875.396-7868833.020+34%-3469676.372-41%-7433175.598+27%-7433175.598+27%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.140-0.024-83%-0.019-87%0.065-316%0.065-316%
 EOD+3 -5MRQTTM+15 -14YOY+4 -255Y+9 -2010Y+9 -20

3.2. Fundamental Score

Let's check the fundamental score of Forte Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.097
Price to Book Ratio (EOD)Between0-10.730
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than16.864
Current Ratio (MRQ)Greater than110.455
Debt to Asset Ratio (MRQ)Less than10.094
Debt to Equity Ratio (MRQ)Less than10.104
Return on Equity (MRQ)Greater than0.15-0.166
Return on Assets (MRQ)Greater than0.05-0.151
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Forte Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.665
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Total Other Income Expense Net 58389634130116245-823-578



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets38,980
Total Liabilities3,666
Total Stockholder Equity35,314
 As reported
Total Liabilities 3,666
Total Stockholder Equity+ 35,314
Total Assets = 38,980

Assets

Total Assets38,980
Total Current Assets38,327
Long-term Assets653
Total Current Assets
Cash And Cash Equivalents 11,961
Short-term Investments 25,164
Other Current Assets 165
Total Current Assets  (as reported)38,327
Total Current Assets  (calculated)37,290
+/- 1,037
Long-term Assets
Property Plant Equipment 109
Long-term Assets Other 53
Long-term Assets  (as reported)653
Long-term Assets  (calculated)162
+/- 491

Liabilities & Shareholders' Equity

Total Current Liabilities3,666
Long-term Liabilities0
Total Stockholder Equity35,314
Total Current Liabilities
Accounts payable 1,424
Total Current Liabilities  (as reported)3,666
Total Current Liabilities  (calculated)1,424
+/- 2,242
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)35,314
Total Stockholder Equity (calculated)0
+/- 35,314
Other
Capital Stock36
Common Stock Shares Outstanding 36,335
Net Invested Capital 35,314
Net Working Capital 34,661
Property Plant and Equipment Gross 118



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-03-31
> Total Assets 
0
0
28,311
22,730
61,239
57,068
52,887
47,390
43,306
41,304
39,720
45,128
41,997
36,708
31,184
47,879
38,980
38,98047,87931,18436,70841,99745,12839,72041,30443,30647,39052,88757,06861,23922,73028,31100
   > Total Current Assets 
0
4,919
28,144
21,617
59,898
55,872
51,881
46,556
42,520
40,411
38,846
44,594
41,511
36,271
30,747
47,102
38,327
38,32747,10230,74736,27141,51144,59438,84640,41142,52046,55651,88155,87259,89821,61728,1444,9190
       Cash And Cash Equivalents 
0
0
27,749
20,175
58,765
54,762
50,795
45,665
42,044
40,035
38,548
44,048
41,100
35,902
20,438
21,144
11,961
11,96121,14420,43835,90241,10044,04838,54840,03542,04445,66550,79554,76258,76520,17527,74900
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,987
25,041
25,164
25,16425,0419,98700000000000000
       Other Current Assets 
0
700
321
713
176
219
189
144
88
89
94
119
70
109
129
94
165
16594129109701199489881441892191767133217000
   > Long-term Assets 
0
0
167
1,113
1,341
1,196
1,006
834
786
893
874
534
486
437
437
777
653
6537774374374865348748937868341,0061,1961,3411,11316700
       Property Plant Equipment 
0
137
124
110
97
83
70
0
0
0
0
0
0
0
30
98
109
109983000000007083971101241370
       Other Assets 
0
43
43
1,003
1,244
1,113
936
834
786
893
874
534
0
437
0
0
0
00043705348748937868349361,1131,2441,00343430
> Total Liabilities 
0
0
3,433
2,411
2,259
2,370
2,978
3,740
1,758
1,256
1,513
2,293
3,179
3,760
6,300
7,471
3,666
3,6667,4716,3003,7603,1792,2931,5131,2561,7583,7402,9782,3702,2592,4113,43300
   > Total Current Liabilities 
0
1,356
3,433
2,411
2,259
2,370
2,978
3,740
1,758
1,256
1,513
2,293
3,179
3,760
6,300
7,471
3,666
3,6667,4716,3003,7603,1792,2931,5131,2561,7583,7402,9782,3702,2592,4113,4331,3560
       Accounts payable 
0
668
2,567
1,513
1,240
1,206
985
2,330
946
576
698
1,191
1,153
1,342
3,006
5,354
1,424
1,4245,3543,0061,3421,1531,1916985769462,3309851,2061,2401,5132,5676680
       Other Current Liabilities 
0
0
133
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000013300
   > Long-term Liabilities 00000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
106
106
262
291
0
0
0
0
0
0
0000002912621061060000000
> Total Stockholder Equity
0
0
24,878
20,319
58,980
54,698
49,909
43,650
41,548
40,048
38,207
42,835
38,818
32,948
24,884
40,408
35,314
35,31440,40824,88432,94838,81842,83538,20740,04841,54843,65049,90954,69858,98020,31924,87800
   Common Stock
0
1
11
11
13
13
14
15
15
15
15
21
0
21
0
0
0
0002102115151515141313111110
   Retained Earnings Total Equity00000000000000000
   Accumulated Other Comprehensive Income 00000000000000000
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 00000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-32,486
Operating Income-32,486-32,486
 
Operating Expense (+$)
Research Development21,862
Selling General Administrative10,624
Selling And Marketing Expenses-
Operating Expense32,48632,486
 
Net Interest Income (+$)
Interest Income1,124
Interest Expense--
Other Finance Cost-0
Net Interest Income1,124
 
Pretax Income (+$)
Operating Income-32,486
Net Interest Income1,124
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-31,476-32,372
EBIT - interestExpense = 0
-31,476
-31,476
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--31,476
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-31,476
Tax Provision--
Net Income From Continuing Ops-31,476-31,476
Net Income-31,476
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-114-1,124
 

Technical Analysis of Forte Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Forte Biosciences Inc. The general trend of Forte Biosciences Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Forte Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Forte Biosciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.675 < 0.75 < 0.775.

The bearish price targets are: 0.655 > 0.6 > 0.56.

Tweet this
Forte Biosciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Forte Biosciences Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Forte Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Forte Biosciences Inc.

Forte Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartForte Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Forte Biosciences Inc. The current adx is .

Forte Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Forte Biosciences Inc.

Forte Biosciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Forte Biosciences Inc.

Forte Biosciences Inc Daily Relative Strength Index (RSI) ChartForte Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Forte Biosciences Inc.

Forte Biosciences Inc Daily Stochastic Oscillator ChartForte Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Forte Biosciences Inc.

Forte Biosciences Inc Daily Commodity Channel Index (CCI) ChartForte Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Forte Biosciences Inc.

Forte Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartForte Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Forte Biosciences Inc.

Forte Biosciences Inc Daily Williams %R ChartForte Biosciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Forte Biosciences Inc.

Forte Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Forte Biosciences Inc.

Forte Biosciences Inc Daily Average True Range (ATR) ChartForte Biosciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Forte Biosciences Inc.

Forte Biosciences Inc Daily On-Balance Volume (OBV) ChartForte Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Forte Biosciences Inc.

Forte Biosciences Inc Daily Money Flow Index (MFI) ChartForte Biosciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Forte Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-30 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-15 00:00:00MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20 00:00:00MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-19 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-15 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-01 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-06 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-08 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-04 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Forte Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Forte Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.665
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Forte Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Forte Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Forte Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Forte Biosciences Inc

I send you an email if I find something interesting about Forte Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Forte Biosciences Inc.

Receive notifications about Forte Biosciences Inc in your mailbox!